News

Published on 11 May 2023 on Zacks via Yahoo Finance

NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall


Article preview image

NuVasive, Inc. NUVA delivered adjusted earnings per share (EPS) of 47 cents for first-quarter 2023, down 12.9% year over year. However, the figure exceeded the Zacks Consensus Estimate by 14.6%.

The one-time adjustments include expenses associated with certain amortization, litigation settlement and business transition costs among others.

GAAP loss per share was 2 cents against the year-ago earnings of 35 cents.

NASDAQ.ISRG price evolution
NYSE.EW price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls

Edwards Lifesciences reports strong contributions from all of the product groups - TAVR, TTMT and...

Zacks 25 Oct 2024

Earnings call: Edwards Lifesciences reports robust third-quarter growth By...

Edwards Lifesciences Corporation (NYSE: NYSE:EW), a global leader in patient-focused medical...

Investing.com 25 Oct 2024

Here’s Why Edwards Lifesciences Corporation (EW) Detracted

Wedgewood Partners, an investment management company, released its third-quarter 2024 investor...

Insider Monkey · via Yahoo Finance 24 Oct 2024

Does Edwards Lifesciences Corporation (EW) Have Attractive Growth Opportunities?

Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid...

Insider Monkey · via Yahoo Finance 22 Jun 2024

Edwards Lifesciences Corporation (NYSE:EW) is favoured by institutional owners...

Key Insights Significantly high institutional ownership implies Edwards Lifesciences' stock price...

Simply Wall St. · via Yahoo Finance 22 Jun 2024

A fantastic week for Edwards Lifesciences Corporation's (NYSE:EW) 84% institutional owners, one-year...

Key Insights Given the large stake in the stock by institutions, Edwards Lifesciences' stock pric...

Simply Wall St. via Yahoo Finance 21 May 2024

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy' -...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifescienc...

Benzinga 1 May 2024

Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript

Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript April 25, 2024 Edward...

Insider Monkey via Yahoo Finance 30 Apr 2024

Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance By Investing.com

Edwards Lifesciences Corporation (NYSE: NYSE:EW), a leader in patient-focused innovations for...

Investing.com 29 Apr 2024